JCRB0825 YMB-1-E
Cell information
Important Notice(s)JCRB0823 YMB-1, JCRB0825 YMB-1-Eについてのご注意
JCRB0823 YMB-1, JCRB0825 YMB-1-E: the problem of origin
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0825 | Cell Name | YMB-1-E |
---|---|---|---|
Profile | breast cancer, exhibit the same DNA profile as other breast carcinoma cell line ZR-75-1. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 55 |
Identity | available | Tissue for Primary Cancer | mammary |
Case history | Metastasis | ||
Tissue Metastasized | Genetics | breast cancer | |
Life Span | Crisis PDL | ||
Morphology | Character | breast cancer | |
Classify | Established by | Yamane,M. | |
Registered by | Akiyama,M. | Regulation for Distribution | |
Comment | Year | 1987 | |
Medium | RPMI1640 medium with 10% fetal calf serum | Methods for Passages | |
Cell Number on Passage | split ratio=1/6 | Race | |
CO2 Conc. | 5 % | Tissue Sampling | breast |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | not tested | ||||||
CMV | - | parvoB19 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
EBV | - | HBV | - | ||||||
HHV6 | - | HTLV-1 | - | ||||||
HHV7 | - | HTLV-2 | - | ||||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:6534930 | Establishment and characterization of new cell line (YMB-1) derived from human breast carcinoma. Yamane M,Nishiki M,Kataoka T,Kishi N,Amano K,Nakagawa K,Okumichi T,Naito M,Ito A,Ezaki H Hiroshima J Med Sci. 1984 Dec;33(4):715-20 |
Images |
---|
LOT Information
Cell No. | JCRB0825 | Cell Name | |
---|---|---|---|
LOT No. | 06142004 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum (FBS lot; GIBCO 3762782S) | Temperature | 37 C |
Cell Density at Seeding | 0.6 - 1.2 x 10^5 cells/ml | Methods for Passages | dilution (suspension culture) |
Doubling Time | 45 hrs | Cell Number in Vial (cells/1ml) | 8.2 x 10^5 |
Viability at cell freezing (%) | 96 | Antibiotics Used | free |
Passage Number | P69 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmes as human by NP, G6PD, MD, LD |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0825 | Cell Name | |
---|---|---|---|
LOT No. | 091195 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum | Temperature | 37 |
Cell Density at Seeding | Methods for Passages | 0.25% trypsin and dilute in fresh medium. Change medium twice a week | |
Doubling Time | Cell Number in Vial (cells/1ml) | ||
Viability at cell freezing (%) | Antibiotics Used | ||
Passage Number | PDL | ||
Sterility: MYCOPLASMA | Sterility: BACTERIA | ||
Sterility: FUNGI | Isozyme Analysis | ||
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |